NASDAQ: SLP
Simulations Plus, Inc.CIK 0001023459 · SIC 7373 · Computer Integrated Systems Design
Small
Revenue $79M
Assets $153M
as of Aug 16, 2026
Every 8-K is open in full. Other 10-Ks and 10-Qs show a 3-bullet preview. A free account reads 3 more full reports a month. Generating a report requires a verified account.
Sign up freeWant to see a complete report first? Today's free report (COTY 10-K) is open in full — no account needed.
8-K
Filed Aug 13, 2026
· Period ending Aug 13, 2026
Summary not yet generated.
8-K
Filed Jul 9, 2026
· Period ending Jul 9, 2026
Summary not yet generated.
Partner
Trade SLP commission-free
Open an account, get a free stock.
Investing involves risk. Free stock terms apply.
10-Q
Filed Jul 9, 2026
· Period ending May 31, 2026
Red flag
SLP: revenue $21.9M, net income $3.6M. SLP returns to profit, gross margin +500bp, as Altaris merger pending regulatory approval
5 material changes detected. Sign up free to read the summary.
8-K
Filed Jun 17, 2026
· Period ending Jun 15, 2026
Summary not yet generated.
8-K
Filed Jun 16, 2026
· Period ending Jun 15, 2026
Summary not yet generated.
10-Q
Filed Apr 10, 2026
· Period ending Feb 28, 2026
Summary not yet generated.
10-K
Filed Dec 1, 2025
· Period ending Aug 31, 2025
Summary not yet generated.
10-Q
Filed Jul 15, 2025
· Period ending May 31, 2025
Summary not yet generated.
10-K
Filed Oct 30, 2024
· Period ending Aug 31, 2024
Summary not yet generated.
Latest financial statements
From 10-Q filed Jul 9, 2026 (period ending May 31, 2026). As printed on the EDGAR/iXBRL face — not generated by the model.
Condensed Consolidated Statements of Operations and Comprehensive Income (Loss) (Unaudited)
(in thousands, except per common share and common share data)
| Description | Three months ended May 31, 2026 | Three months ended May 31, 2025 | Nine months ended May 31, 2026 | Nine months ended May 31, 2025 |
|---|---|---|---|---|
| Revenues | ||||
| Software | 12,608 | 12,615 | 36,126 | 36,814 |
| Services | 9,278 | 7,748 | 28,472 | 24,905 |
| Total revenues | 21,886 | 20,363 | 64,598 | 61,719 |
| Cost of revenues | ||||
| Software | 1,513 | 2,540 | 4,573 | 7,765 |
| Services | 5,246 | 4,791 | 17,864 | 17,577 |
| Total cost of revenues | 6,759 | 7,331 | 22,437 | 25,342 |
| Gross profit | 15,127 | 13,032 | 42,161 | 36,377 |
| Operating expenses | ||||
| Research and development | 3,406 | 1,216 | 9,856 | 5,207 |
| Sales and marketing | 2,538 | 2,680 | 8,647 | 9,248 |
| General and administrative | 4,684 | 6,141 | 12,816 | 16,089 |
| Impairments | — | 77,221 | — | 77,221 |
| Total operating expenses | 10,628 | 87,258 | 31,319 | 107,765 |
| Income (loss) from operations | 4,499 | (74,226) | 10,842 | (71,388) |
| Other income, net | 307 | 182 | 820 | 1,122 |
| Income (loss) before income taxes | 4,806 | (74,044) | 11,662 | (70,266) |
| Income tax (expense) benefit | (1,231) | 6,727 | (2,876) | 6,229 |
| Net income (loss) | 3,575 | (67,317) | 8,786 | (64,037) |
| Earnings per share | ||||
| Basic | 0.18 | (3.35) | 0.44 | (3.19) |
| Diluted | 0.18 | (3.35) | 0.43 | (3.19) |
| Weighted-average common shares outstanding | ||||
| Basic | 20,209 | 20,113 | 20,170 | 20,092 |
| Diluted | 20,239 | 20,113 | 20,233 | 20,092 |
| Other comprehensive income (loss), net of tax | ||||
| Foreign currency translation adjustments | 10 | 41 | 15 | (27) |
| Unrealized (losses) gains on available-for-sale securities | (8) | — | (14) | 4 |
| Comprehensive income (loss) | 3,577 | (67,276) | 8,787 | (64,060) |
Condensed Consolidated Balance Sheets (Unaudited)
(in thousands, except per common share and common share data)
| Description | May 31, 2026 | August 31, 2025 |
|---|---|---|
| ASSETS | ||
| Current assets | ||
| Cash and cash equivalents | 35,324 | 30,853 |
| Accounts receivable, net of allowance for credit losses of $59 and $187 | 17,202 | 9,717 |
| Prepaid income taxes | 263 | 1,777 |
| Prepaid expenses and other current assets | 7,670 | 7,702 |
| Short-term investments | 14,666 | 1,500 |
| Total current assets | 75,125 | 51,549 |
| Long-term assets | ||
| Capitalized computer software development costs, net of accumulated amortization of $24,187 and $21,863 | 11,203 | 11,117 |
| Property and equipment, net | 513 | 880 |
| Operating lease right-of-use assets | 395 | 407 |
| Intellectual property, net of accumulated amortization of $9,822 and $9,021 | 5,396 | 6,197 |
| Other intangible assets, net of accumulated amortization of $5,127 and $4,399 | 11,074 | 11,896 |
| Goodwill | 43,717 | 43,717 |
| Deferred tax assets, net | 4,168 | 4,774 |
| Other assets | 1,385 | 1,399 |
| Total assets | 152,976 | 131,936 |
| LIABILITIES AND SHAREHOLDERS' EQUITY | ||
| Current liabilities | ||
| Accounts payable | 2,234 | 470 |
| Accrued compensation | 4,888 | 2,010 |
| Accrued expenses | 1,054 | 1,343 |
| Operating lease liability current portion | 112 | 206 |
| Deferred revenue | 5,278 | 2,696 |
| Total current liabilities | 13,566 | 6,725 |
| Long-term liabilities | ||
| Operating lease liability net of current portion | 375 | 410 |
| Total liabilities | 13,941 | 7,135 |
| Commitments and contingencies | ||
| Shareholders' equity | ||
| Preferred stock, $0.001 par value 10,000,000 shares authorized; no shares issued and outstanding | — | — |
| Common stock, $0.001 par value; 50,000,000 shares authorized, 20,216,438 and 20,137,480 shares issued and outstanding as of May 31, 2026, and August 31, 2025 | 20 | 20 |
| Additional paid-in capital | 164,863 | 159,416 |
| Accumulated deficit | (25,578) | (34,364) |
| Accumulated other comprehensive loss | (270) | (271) |
| Total shareholders' equity | 139,035 | 124,801 |
| Total liabilities and shareholders' equity | 152,976 | 131,936 |
Condensed Consolidated Statements of Cash Flows (Unaudited)
(in thousands)
| Description | Nine months ended May 31, 2026 | Nine months ended May 31, 2025 |
|---|---|---|
| Cash flows from operating activities | ||
| Net income (loss) | 8,786 | (64,037) |
| Adjustments to reconcile net income (loss) to net cash provided by operating activities | ||
| Depreciation and amortization | 4,261 | 6,857 |
| Change in fair value of contingent consideration | — | (640) |
| Discharge of holdback obligation related to Immunetrics acquisition | — | (224) |
| Amortization of investment premiums | 7 | (64) |
| Stock-based compensation | 4,894 | 4,830 |
| Deferred income taxes | 606 | (8,081) |
| Loss from disposal of assets | 69 | 23 |
| Impairments | — | 77,221 |
| Currency translation adjustments | 15 | (28) |
| (Increase) decrease in | ||
| Accounts receivable | (7,485) | (5,644) |
| Prepaid income taxes | 1,514 | 1,243 |
| Prepaid expenses and other current assets | (130) | 274 |
| Increase (decrease) in | ||
| Accounts payable | 1,764 | 1,061 |
| Other liabilities | 2,472 | (2,600) |
| Deferred revenue | 2,582 | 2,348 |
| Net cash provided by operating activities | 19,355 | 12,539 |
| Cash flows from investing activities | ||
| Purchases of property and equipment | (139) | (449) |
| Vendor refund related to property and equipment | 310 | — |
| Purchase of short-term investments | (28,188) | (6,500) |
| Proceeds from maturities of short-term investments | 15,001 | 14,017 |
| Proceeds from sales of investments | — | 995 |
| Purchased intangibles | (11) | (368) |
| Net working capital & excess cash settlement Pro-ficiency acquisition | — | (227) |
| Capitalized computer software development costs | (2,343) | (2,115) |
| Net cash (used in) provided by investing activities | (15,370) | 5,353 |
| Cash flows from financing activities | ||
| Payments on contracts payable | — | (1,576) |
| Proceeds from the exercise of stock options | 486 | 323 |
| Net cash provided by (used in) financing activities | 486 | (1,253) |
| Net increase in cash and cash equivalents | 4,471 | 16,639 |
| Cash and cash equivalents, beginning of period | 30,853 | 10,311 |
| Cash and cash equivalents, end of period | 35,324 | 26,950 |
| Supplemental disclosures of cash flow information | ||
| Income taxes paid | 756 | 1,020 |
| Supplemental disclosures of non-cash activities | ||
| Measurement period adjustments | — | 956 |
| Non-cash investing and financing activities | ||
| Right of use assets capitalized | 47 | — |
Amounts as printed on the EDGAR/iXBRL face — (in thousands, except per common share and common share data); (in thousands). Labels, columns, and figures are the filing face, not a GAAP stencil. Interactive statements & notes on EDGAR ↗